Akebia Therapeutics, Inc. (AKBA) Stock On the Rise Following Progression of Vadadastut’s Commercial Development
Akebia Therapeutics, Inc. (AKBA) stock prices were up by a marginal 0.29% as of the market closing on May 28th, 2021, bringing the price per share up to USD$3.51 at the end of the trading day. Subsequent pre-market fluctuations have seen the stock rise by a significant 9.97%, bringing it up to USD$3.86. NDA Submission […]
